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Abstract
Introduction: Colorectal cancer most commonly metastasizes to the regional lymph nodes, liver,
bone, lung, and brain. Metastases to mediastinal lymph nodes is a rare entity which has never been
reported to be solitary.
Case report: We herein describe a 67-year-old male patient with a solitary mediastinal lymph
node metastasis three years following the resection of his primary rectosigmoid carcinoma.
Pathological characteristics of the metastatic tissue and technical limitations in imaging modalities
resulted in incongruity between follow-up CT and PET scans. Diagnosis of this distant metastasis
has been confirmed through a mediastinoscopic biopsy.
Conclusion: Attention should be paid to the mediastinum when evaluating PET scan or CT films
during follow-up of patients with colorectal cancer. Using PET/CT instead of separate
morphological and functional data sets favors better detection. Questions still remain concerning
the ideal management protocol of such a presentation, the two main options being locoregional or
chemotherapeutic.
Introduction
Colorectal cancer is the third most common cancer as well
as the third most common cause of cancer death in both
men and women [1]. Rectosigmoid colon continues to be
the most common site while the cecum, ascending and
transverse colon are increasingly reported. Colorectal can-
cer most commonly metastasizes to the regional lymph
nodes, liver, bone, lung, and brain. Rare metastases to
mediastinal lymph nodes from colonic carcinomas have
also been reported [2-5]. Postulated mechanisms of
spread were lymphatic drainage routes of the liver in those
with concurrent liver metastases; and paravertebral
venous or paraaortic lymphatic plexus in those with con-
comitant pelvic or abdominal metastases. Mediastinal
lymphadenopathy, attributed to coexisting sarcoidosis,
has also been reported in one case of colon cancer [6]. To
our knowledge, our report is the first in the literature to
demonstrate solitary mediastinal lymph node metastases
of colorectal carcinoma with no other site involvement.
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Case Report
We describe the case of a 67-year-old man with evidence
of right paratracheal lymph node metastasis three years
following the diagnosis of rectosigmoid carcinoma. In
October 2004, the patient initially presented with symp-
toms and signs of intestinal obstruction. Computed tom-
ography (CT) scan of the abdomen and pelvis showed
diffuse circumferential intramural thickening with associ-
ated streaking of the adjacent fat planes in a short segment
of the sigmoid colon. Sigmoidoscopic biopsy revealed an
infiltrating moderately differentiated adenocarcinoma.
Subtotal colectomy was eventually performed. Pathologic
examination of the resected tissue revealed a five centim-
eter tumor invading the muscularis propria and perico-
lonic fat. Metastatic adenocarcinoma was noted in ten out
of fifty peri-tumoral and mesenteric lymph nodes with
extracapsular extension. The patient was eventually diag-
nosed with stage III adenocarcinoma of the rectosigmoid
colon and given six cycles of adjuvant chemotherapy. In
December 2006, a follow up total body CT scan identified
an enlarged 1 × 1 cm right paratracheal lymph node, with
no evidence of pulmonary infiltrates, masses or fluid in
the pleural cavities. There were no other significant find-
ings in the pelvis or abdomen. The recommendation was
to perform a fluor-18-deoxyglucose-positron emission
tomography (18F-FDG PET) scan, which did not show any
evidence of active disease; and hence, tumoral metastasis
was ruled out and no action was taken. In October 2007,
the previously identified lymph node appeared to have
increased in size to approximately 2.2 cm, with the
remainder of the CT scan being insignificant. Mediastino-
scopic biopsy of the lymph node was done and revealed
metastatic adenocarcinoma, similar to that of the colon
(Figure 1A; ×200). Biopsy of another paratracheal lymph
node showed two cell clusters of metastatic adenocarci-
noma that were only identified by immunohistochemical
analysis (Figure 1B; ×400). The metastatic tumor was pos-
itive for cytokeratin AE1/AE3 and cytokeratin 20 (Figure
1C; ×400), weakly positive for cytokeratin 7 (Figure 1D;
×400), and negative for thyroid transcription factor-1
(TTF1), confirming its colonic origin. Consequently, a
total body 18F-FDG PET scan was requested which now
identified the lymph node (Figure 2), and revealed no
other significant findings. All through out the follow-up
period the patient never had any respiratory or gastroin-
testinal symptoms. Ca19-9 and CEA serum levels were
always within the normal range.
Discussion
We propose the following explanations for the incongru-
ity between the follow-up imaging studies performed on
the patient described in this report. 18F-FDG PET scan has
proven superior to morphologic imaging procedures
when assessing lymph node involvement based on func-
tional data evaluating tumor metabolism [7]. A meta-
analysis of the most recent literature showed that chang-
ing the therapy plan by the use of 18F-FDG PET scan in
patients with colorectal metastatic cancer occurs in 31.6%
of the cases [8]. However, small malignant lesions may
not show increased tracer uptake since current PET-detec-
tors provide an in-plane spatial resolution of only 4–5
mm. This limitation is most heightened in the thorax
where lesion detection on PET is further compromised by
respiratory motion (shallow breathing during PET acqui-
sition) [9]. Furthermore, the extensive fibrosis evident by
pathological examination of the mediastinal lymph node
in our case might have led to a decrease in uptake of 18F-
FDG during the initial PET scan in April 2006. Several
studies, evaluating patients with different oncological dis-
eases, have reported outstanding results concerning
tumor staging when using PET/CT instead of separate
morphological and functional data sets [10,11].
Upgrading from stage III to stage IV ensues after detection
of this distant metastasis. However, one question still
Colonic tissue in paratracheal nodes Figure 1
Colonic tissue in paratracheal nodes. Paratracheal nodal 
involvement by metastatic adenocarcinoma (A) [H&E, 200×]. 
The tumor cells are strongly positive for CK20 (B) [400×], 
weakly positive for CK7 (C) [400×]. Micrometastasis in 
another paratracheal lymph node (D) [400×].
PET scan of thorax Figure 2
PET scan of thorax. 18F-FDG PET scan of the thorax 
showing a 2.2 cm enlarged right paratracheal lymph node.Publish with BioMed Central    and   every 
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remains: should the management of this patient rely on
systemic chemotherapy only or could the patient benefit
from loco-regional radiation and/or surgical resection?
The rationale would be that resection or radiation of the
mediastinal lymph node may prevent possibly fatal com-
plications caused by tracheal and major vascular involve-
ment; however, no evidence to support this reasoning
currently exists.
Conclusion
Our case report suggests that attention should be paid to
the mediastinum when evaluating PET scan or CT films
during follow-up of patients with colorectal cancer. More-
over, despite the fact that the 18F-FDG PET scan has high
specificity for colorectal metastases; all suspected lesions,
identified though morphological imaging, must be fur-
ther investigated if they can change the therapeutic plan.
However, the choice between locoregional and chemo-
therapeutic subsequent management remains unclear in
the case of solitary mediastinal metastasis.
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